Antimicrobial resistance is a growing threat to good health and well-being
Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.
11 November, 2018
Image courtesy of Pfizer.
Sponsored by Pfizer
- Antimicrobial-resistant pathogens are one of the largest threats to global health today.
- As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
- If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
- Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
- By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
Keep reading
Show less
What it takes to get vaccines from the lab to the field
Pfizer's Susan Silbermann explains the superhuman effort involved in getting vaccines to the people who need them most.
02 November, 2018
Sponsored
- The United Nations Sustainable Development Goals (SDG) are a set of 17 directives to be completed by a 2030 deadline, with the aim of significantly improving quality of life for all people on Earth.
- Pfizer has made a commitment to SDG #3: Good health and well-being for all.
- Africa bears 25% of the world's disease burden yet has just 3% of the world's health workers. So how do you get life-saving vaccines to world's most vulnerable?
- Pfizer partners with several organizations to help strengthen the ability to deliver vaccines in developing countries. By training local healthcare workers we can remove some of the obstacles in getting a child vaccinated.
- Recent innovations in Pfizer's vaccine technology, like the multi-dose vial, have reduced shipping and storage space, which is critical as vaccines need to be transported and stored at very specific temperatures.
How to vaccinate the world’s most vulnerable? Build global partnerships.
Pfizer's partnerships strengthen their ability to deliver vaccines in developing countries.
02 November, 2018
Susan Silbermann, Global President of Pfizer Vaccines, looks on as a health care worker administers a vaccine in Rwanda. Photo: Courtesy of Pfizer.
Sponsored by Pfizer
- Community healthcare workers face many challenges in their work, including often traveling far distances to see their clients
- Pfizer is helping to drive the UN's sustainable development goals through partnerships.
- Pfizer partnered with AMP and the World Health Organization to develop a training program for healthcare workers.
Keep reading
Show less
Sponsored by Pfizer
- The United Nations Sustainable Development Goals (SDG) are a set of 17 directives to be completed by a 2030 deadline, with the aim of significantly improving quality of life for all people on Earth.
- Pfizer's commitment to the UN's SDG #3, Good Health and Well-being, is exemplified by its mission to improve global health through a combination of local and global programs catalyzed by innovative health leaders.
- In 1998, Pfizer embarked on a 22-year mission to eradicate trachoma by 2020.Trachoma is an infectious eye disease that can cause irreversible blindness or vision impairment. So far, it has been eradicated in six countries.
- Pfizer is a committed partner in improving global health, helping to provide a number of critical cancer medications to six African countries where an estimated 44 percent of all cancer cases in sub-Saharan Africa occur each year
Pfizer
Pfizer Corporate Responsibility develops programs that help expand global access to medicines by providing direct assistance to underserved populations. Our initiatives include providing product donations and steep discounts that help patients access the medicine they need. We also collaborate with Pfizer business teams and nonprofit organizations to help shape sustainable business models that address affordability and the vast differences in economies around the world.